Effect of a prostaglandin I2 analogue, beraprost sodium, on burn-induced gastric mucosal injury in rats

Burns

Volumn 23, Issue 3, 1997, Pages 232-237

  Battal, M N ^a   Hata, Y ^a   Matsuka, K ^a   Ito, O ^a   Matsuda, H ^a   Yoshida, Y ^a   Kawazoe, T ^a   Nagao, M ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Burn; Gastric; Prostacyclin; Prostaglandin I2; Ulcer

Indexed keywords

BERAPROST; PROSTACYCLIN; PROSTAGLANDIN DERIVATIVE; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VISCOSITY; BURN; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LASER DOPPLER FLOWMETRY; MALE; NONHUMAN; RAT; STOMACH BLOOD FLOW; STOMACH MUCOSA LESION; STRESS ULCER; ANIMAL; BLOOD FLOW VELOCITY; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; STOMACH MUCOSA; STOMACH ULCER; STRESS; VASCULARIZATION;

ANIMALS; BLOOD FLOW VELOCITY; BURNS; DISEASE MODELS, ANIMAL; EPOPROSTENOL; GASTRIC MUCOSA; LASER-DOPPLER FLOWMETRY; MALE; PLATELET AGGREGATION INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; STOMACH ULCER; STRESS; VASODILATOR AGENTS;

EID: 0030611627     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(96)00108-8     Document Type: Article

References (40)

1. Fruit Jr BA, Goodwin Jr CW. Stress ulcer disease in the burned patient. World J Surg 1981; 5: 209-222.
2. Cho CH, Koo MWL, Garg GP, Ogle CW. Stress induced gastric ulceration: Its aethiology and clinical implications. Scan J Gastroenterol 1992; 27: 257-262.
3. Harlan JM, Harker LA. Hemostasis, thrombosis and thromboembolic disorders: The role of arachidonic acid metabolites in platelet-vessel wall interactions. Med Clin North Am 1981; 65(4): 855-880.
4. 2 levels in the plasma of burned and septic burned patients. Surg Gynecol Obstet 1984; 159: 210-213.
5. Huang YS, Li AN, Yang ZC. Roles of thromboxane and prostacyclin in the pathogenesis of acute respiratory failure in burn patients combined with inhalation injury. Burns 1992; 18(6): 452-455.
6. Yuesheng H, Li AN, Zongcheng Y. Role of thromboxane and its inhibitor anisodamine in burn shock. Burns 1990; 16(4): 249-253.
7. Yuesheng H, Li AN, Zongcheng Y. A prospective study on the pathogenesis of multiple organ failure in severely burned patients. Burns 1992; 18(1): 30-34.
8. 2 release is restored by treatment with lazaroid. Prostaglandins 1993; 45: 535-546.
9. Whittle BJR, Broughton-Smith NK, Moncada S, Vane JR. Prostaglandins 1978; 15: 955-967.
10. 2 derivative, on gastroduodenal lesions and secretory responses in the rat. Digestion 1990; 45(2): 61-71.
11. Nickolson RC, Town MH, Vorburggenn H. Prostacyclin analogs. Med Res Rev 1985; 5: 1-53.
12. 2 during long term intraarterial prostacyclin infusion in patients with peripheral vascular disease-A rebound phenomenon?. Prostaglandins 1981; 21: 49.
13. 2) in aqueous solutions. Prostaglandins 1978; 15: 943-954.
14. El Tahir KEH, Williams KI, Betteridge DJ. Differences in the stability of prostacyclin in human, rabbit and rat plasma. Prostaglandins Leukot Med 1983; 10: 109-114.
15. Sasaki G, Pang CY. Experimental evidence for involvement of prostaglandins in viability of acute flaps: Effects on viability and mode of action. Plast Reconstr Surg 1981; 67: 335-340.
16. Sturzebecher S, Harberey M, Mullar B et al. Pharmacological profile of a novel carbacyclin derivative with high metabolic stability and oral activity in the rat. Prostaglandins 1986; 31: 95-109.
17. Sim AK, McCraw AP, Cleland ME, Nishio S, Umetsu T. The effect of a stable prostacyclin analogue on platelet function and experimentally induced thrombosis in the microcirculation. Arzneimittelforschung Drug Res 1985; 35: 1816-1818.
18. 2 analogue. Jpn J Pharmacol 1987; 43: 81-90.
19. 2 analogue, beraprost sodium, (Procylin™): An experimental study in rats. Burns 1996; 22: 531-538.
20. Whittle BJR, Lopez-Belmonte J, Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: Interactions with prostanoids and sensory neuropepdides in the rat. Br J Pharmocol 1990; 99: 607-611.
21. Masuda E, Kawano S, Nagano K et al. Role of endogenous endothelin in pathogenesis of ethanol induced gastric mucosal injury in rats. Am J Physiol 1993; 265: G474-G481.
22. 2 moderate postischemic renal failure. Surgery 1985; 98(2): 207-212.
23. Del Beccaro EJ, Robson CM, Heggers JP, Swaminathan R. The use of specific thromboxane inhibitors to preserve the dermal microcirculation after burning. Surgery 1980; 87(2): 137-141.
24. Hyman AL, Mathé AA, Lippton HL, Kadowitz PJ. Prostaglandins and lung. Med Clin North Am 1981; 65(4): 789-808.
25. Whittle BJR, Moncada S. Pharmacological interactions between prostacyclin and thromboxanes. Br Med Bull 1983; 39: 232-238.
26. Alemayehu A, Sawmiller D, Chou BS et al Intestinal prostacyclin and thromboxane production in inreversible hemorrhagic shock. Circ Shock 1987; 23: 119-130.
27. Carter EA, Thompkins RG, Yarmush ML et al. Redistribution of blood flow thermal injury and hemorrhagic shock. J Appl Physiol 1988; 65(4): 1782-1788.
28. Carter EA, Udall JN, Kirkham SE, Walker WA. Thermal injury and gastrointestinal nutrient absorption and DNA synthesis. J Burn Rehabil 1986; 7: 469-474.
29. Reed MK, Taylor B, Meyers SI. The effect of hypoxia on rat splanchnic prostanoid output. Prostaglandins 1989; 38: 599-608.
30. Xue RJ, Hammerschimidt DE, Coppo P et al. Anisodamine inhibits thromboxane synthesis, granulocyte aggregation, and platelet aggregation. A possible mechanism for its efficacy in bacteremic shock. JAMA 1982; 247: 1458-1460.
31. Demling RH, Lalonde C. Early postburn lipid peroxidation: Effect of ibuprofen and allopurinol. Surgery 1990; 107(1): 85-93.
32. Zachary LS, Heggens JP, Robson MC, Murphy RC. Combined prostacyclin and thromboxane synthetase inhibitor UK-38 485 in flap survival. Ann Plast Surg 1986; 17: 112-115.
33. Knight K, Crabb DJ, Niall M et al. Pharmacologic modification of blood flow in the rabbit with prostacyclin and related drugs. Plast Reconstr Surg 1985; 75: 692-702.
34. Crabb DJ, Niall M, Knight K, Angus J, O'Brien B. Topical use of prostacyclin in microvascular surgery. Br J Plast Surg 1985; 38: 383-388.
35. Belch JJF, McKay A, McArdle B et al. Epoprostenol (prostacyclin) and severe arterial disease: a double blind trial. Lancet 1983; I: 313-315.
36. 2 analogue. Br J Pharmacol 1986; 89: 703-711.
37. Umetsu T, Murata T, Nishio S. Studies on the antiplatelet effect of the stable epoprostenol analogue beraprost sodium and its mechanism of action in rats. Arzneimittelforschung Drug Res 1989; 39: 68-73.
38. Murata T, Murai T, Kanai T et al. General pharmacology of beraprost sodium. 2nd communication: Effect on the autonomic, cardiovascular and gastrointestinal systems and other effects. Arzneimittelforschung Drug Res 1989; 39: 867-876.
39. 2 clearance, and microsphere estimates of mucosal blood flow. Am J Physiol 1985; 249: G221-G227.
40. Shepherd AP, Riedel GL, Kiel JW et al. Evaluation of an infrared laser-Doppler, blood flowmeter. Am J Physiol 1987; 252: G832-G839.